SEC Form 4 · accession 0001209191-18-062061
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Mates
Officer — Chairman, President & CEO · Director
Period of report
Dec 10, 2018
Accepted (ET)
Dec 11, 2018 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2018 | M | 50,000 | $1.50 | A | 1,138,707 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.50 | Dec 10, 2018 | M | 50,000 | D | — | Dec 18, 2018 | Common Stock | 0 | 0 | D |
Explanation of responses
- F1All shares underlying this option have vested.
Remarks
This Form 4 reports the acquisition of 50,000 shares of the Issuer's common stock by the reporting person upon the exercise of a stock option that was expiring in December 2018.